The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Trial leads are used to evaluate response to neuromodulation therapies prior to a definitive implantation. After the trial period, currently available leads require removal and replacement with a permanent lead. Unfortunately, successful trials are often followed by inefficacious permanent implants, potentially due to positional placement sensitivity and/or scar tissue at the implant site. To address this issue, we developed the fully needle-implanted InjectrodeⓇ which facilitates a trial period, followed by a straightforward conversion to chronic therapy through either: 1) augmented transcutaneous stimulation, or 2) attachment to implanted pulse generators as demonstrated here in a rodent sciatic nerve model.
